Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A High-Value Global Licensing Agreement Under the deal, Fosuns subsidiary Yao Pharma will grant Pfizer an exclusive worldwide license to develop, manufacture, and commercialize its oral GLP-1R agonists
How GLP-1s Support Your Goals GLP-1 medications support weight loss by working on important body processes like: Helping to improve insulin sensitivity Reducing food preoccupation and cravings Supporting balanced blood sugar throughout the day Potentially supporting fat metabolism With a decrease in persistent urges to snack or overeat, it may make it easier to maintain consistent eating patterns during the menopause transition
The analysts remained optimistic that this class of drugs will have the ability to overcome supply issues and enjoy sustained uptake. Additionally, they said we are also optimistic that reimbursement will steadily expand for weight loss, achieving over $100 billion in global sales by 2030.
These medicines work by mimicking a natural hormone in the body that helps regulate blood sugar, appetite, and digestion
Ozempic can reduce HbA1c by about 1% to 1.5%, while Rybelsus typically reduces it by around 0.8% to 1%
/assets/images/provider/photos/2775905.jpeg)
US$ 25.33
US$ 27.81
US$ 21.60
